Association between CYP2C9 polymorphisms and ischemic stroke following endovascular neurointervention

By Subhashaan Sreedharan, Leonid Churilov, Jianxiong Chan, Marian Todaro, Alan Coulthard, Jeffrey Hocking, Kate Mahady, Peter Mitchell, Richard Dowling, Steven Bush, Patrick Kwan, Bernard Yan On May 18, 2020

Polymorphisms in the CYP2C9 gene may be associated with adverse vascular events following endovascular procedures independent of antiplatelet therapy. We aimed to investigate the impact of CYP2C9 loss-of-function polymorphisms on adverse vascular events following neurointervention.